The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | 69,370,868 | 3,424,031 | SH | SOLE | 3,424,031 | 0 | 0 | ||
ABIVAX SA | SPONSORED ADS | 00370M103 | 10,684,699 | 998,570 | SH | SOLE | 998,570 | 0 | 0 | ||
ACELYRIN INC | COM | 00445A100 | 6,990,863 | 937,113 | SH | SOLE | 937,113 | 0 | 0 | ||
ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 3,875,073 | 5,147,547 | SH | SOLE | 5,147,547 | 0 | 0 | ||
AMBRX BIOPHARMA INC | COM | 641871108 | 29,476,800 | 2,070,000 | SH | SOLE | 2,070,000 | 0 | 0 | ||
APOGEE THERAPEUTICS INC | COM | 03770N101 | 237,303,389 | 8,493,321 | SH | SOLE | 8,493,321 | 0 | 0 | ||
APPLIED THERAPEUTICS INC | COM | 03828A101 | 20,937,500 | 6,250,000 | SH | SOLE | 6,250,000 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 25,839,754 | 627,788 | SH | SOLE | 627,788 | 0 | 0 | ||
ASTRIA THERAPEUTICS INC | COM | 04635X102 | 24,774,190 | 3,225,806 | SH | SOLE | 3,225,806 | 0 | 0 | ||
CABALETTA BIO INC | COM | 12674W109 | 58,201,710 | 2,563,952 | SH | SOLE | 2,563,952 | 0 | 0 | ||
CELCUITY INC | COM | 15102K100 | 27,472,289 | 1,885,538 | SH | SOLE | 1,885,538 | 0 | 0 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 27,542,902 | 4,684,167 | SH | SOLE | 4,684,167 | 0 | 0 | ||
DIANTHUS THERAPEUTICS INC | COM | 252828108 | 9,648,142 | 927,706 | SH | SOLE | 927,706 | 0 | 0 | ||
DYNE THERAPEUTICS INC | COM | 26818M108 | 28,913,043 | 2,173,913 | SH | SOLE | 2,173,913 | 0 | 0 | ||
ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 40,895,844 | 2,954,902 | SH | SOLE | 2,954,902 | 0 | 0 | ||
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 5,777,500 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | 7,646,297 | 1,318,327 | SH | SOLE | 1,318,327 | 0 | 0 | ||
HILLEVAX INC | COM | 43157M102 | 33,303,750 | 2,075,000 | SH | SOLE | 2,075,000 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 50,135,955 | 4,092,731 | SH | SOLE | 4,092,731 | 0 | 0 | ||
LYRA THERAPEUTICS INC | COM | 55234L105 | 13,496,107 | 2,575,593 | SH | SOLE | 2,575,593 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 26,280,960 | 11,328,000 | SH | SOLE | 11,328,000 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 59,075,885 | 2,148,214 | SH | SOLE | 2,148,214 | 0 | 0 | ||
MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 1,544,830 | 925,048 | SH | SOLE | 925,048 | 0 | 0 | ||
OCULAR THERAPEUTIX INC | COM | 67576A100 | 34,679,890 | 7,775,760 | SH | SOLE | 7,775,760 | 0 | 0 | ||
OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 1,080,899 | 77,042 | SH | SOLE | 77,042 | 0 | 0 | ||
ORIC PHARMACEUTICALS INC | COM | 68622P109 | 22,341,142 | 2,428,385 | SH | SOLE | 2,428,385 | 0 | 0 | ||
PHARVARIS N V | COM | N69605108 | 95,246,748 | 3,395,606 | SH | SOLE | 3,395,606 | 0 | 0 | ||
PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | 7,878,787 | 353,626 | SH | SOLE | 353,626 | 0 | 0 | ||
RAYZEBIO INC | COM | 75525N107 | 250,574,382 | 4,030,471 | SH | SOLE | 4,030,471 | 0 | 0 | ||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 22,800,339 | 495,983 | SH | SOLE | 495,983 | 0 | 0 | ||
SAVARA INC | COM | 805111101 | 16,450,000 | 3,500,000 | SH | SOLE | 3,500,000 | 0 | 0 | ||
SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | 51,060,805 | 2,372,714 | SH | SOLE | 2,372,714 | 0 | 0 | ||
TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | 18,430,783 | 10,412,872 | SH | SOLE | 10,412,872 | 0 | 0 | ||
TERNS PHARMACEUTICALS INC | COM | 880881107 | 29,186,289 | 4,497,117 | SH | SOLE | 4,497,117 | 0 | 0 | ||
TREVI THERAPEUTICS INC | COM | 89532M101 | 4,586,012 | 3,422,397 | SH | SOLE | 3,422,397 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 84,563,529 | 3,882,623 | SH | SOLE | 3,882,623 | 0 | 0 |